Sunny Pharmtech Inc. (6676.TWO)
TWD 14.35
(-22.85%)
TWD 14.35
(-22.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 120.87 Million TWD | -64.46% |
| 2022 | 340.05 Million TWD | 147.62% |
| 2021 | 137.32 Million TWD | -3.9% |
| 2020 | 142.9 Million TWD | 55.09% |
| 2019 | 92.14 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 173.99 Million TWD | 43.95% |
| 2024 Q2 | 146.94 Million TWD | 13.59% |
| 2023 Q4 | 120.87 Million TWD | 3.37% |
| 2023 FY | 120.87 Million TWD | -64.46% |
| 2023 Q3 | 116.93 Million TWD | -67.66% |
| 2023 Q2 | 361.6 Million TWD | 1.16% |
| 2023 Q1 | 357.43 Million TWD | 5.11% |
| 2022 FY | 340.05 Million TWD | 147.62% |
| 2022 Q4 | 340.05 Million TWD | 0.94% |
| 2022 Q3 | 336.89 Million TWD | 0.0% |
| 2021 FY | 137.32 Million TWD | -3.9% |
| 2020 FY | 142.9 Million TWD | 55.09% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 256.886% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 145.755% |
| Level Biotechnology Inc. | -453.9 Million TWD | 126.629% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 200.25% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 161.544% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 75.818% |
| GlycoNex Incorporation | -148.56 Million TWD | 181.358% |
| VBI | -25.31 Million TWD | 577.449% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | -200.181% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 12.409% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 146.032% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -295.287% |
| Visgeneer Inc. | 31.28 Million TWD | -286.367% |
| Mycenax Biotech Inc. | 207 Million TWD | 41.611% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 117.759% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 190.033% |
| Neith Corporation | -150.31 Million TWD | 180.414% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 80.553% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 309.634% |
| Enimmune corporation | -314.15 Million TWD | 138.474% |
| TaiRx, Inc. | -147.86 Million TWD | 181.742% |
| CHO Pharma, Inc. | -203.79 Million TWD | 159.311% |
| EirGenix Inc. | -4.58 Billion TWD | 102.634% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 242.599% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 103.756% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 138.079% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 710.059% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -279.99% |
| Lukas Biomedical Inc. | 50.75 Million TWD | -138.146% |
| RBC Bioscience Corporation | 422.18 Million TWD | 71.37% |
| BiOptic Inc. | 12.59 Million TWD | -859.903% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 112.799% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 219.101% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 173.177% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 61.613% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 287.918% |
| NaviFUS Corp. | -123.12 Million TWD | 198.166% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -63.227% |
| Sinew Pharma Inc. | -160.34 Million TWD | 175.382% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 149.969% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 135.827% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 129.292% |
| AP Biosciences Inc | -196.52 Million TWD | 161.503% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 82.45% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 1156.842% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 114.568% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 91.095% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 129.134% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 157.74% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 184.018% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 136.568% |
| TCI GENE Inc. | -689.25 Million TWD | 117.537% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 201.625% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 109.232% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -490.104% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 218.652% |
| PharmaEngine, Inc. | -860.8 Million TWD | 114.042% |
| Savior Lifetec Corporation | -812.54 Million TWD | 114.876% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 140.295% |
| OBI Pharma, Inc. | -398.22 Million TWD | 130.353% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 133.077% |
| Acepodia, Inc. | -6.02 Billion TWD | 102.008% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 103.553% |